Hepatic insulin resistance, a hallmark of NAFLD, disrupts systemic metabolic balance by impairing glucose uptake and promoting hepatic gluconeogenesis, thereby exacerbating hyperglycemia and insulin demand, which accelerates the onset of diabetes and cardiovascular complications [34]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.